title: Increased tyrosine kinase activites may lead to the phenotypic differences of gastric cancer cells.
abstract: BACKGROUND
  The aim of this study was to elucidate possible mechanisms responsible for the phenotypic difference in gastric cancer cells between the intestinal type and the diffuse type.
  
  
  METHODS
  The gastric cancer cell lines MKN7 and KATO-III were used. Expression of adhesion molecules and protein tyrosine phosphorylation were examined by immunoblotting. Protein-protein interactions were determined by immunoblotting following immunoprecipitation. ERK activity was assessed by immunoblotting using anti-phospho-ERK antibody.
  
  
  RESULTS
  E-cadherin expression in KATO-III was decreased compared to that in MKN7. The expression of alpha-, beta- and gamma-catenin was not significantly different; beta- and gamma-catenin were highly tyrosine phosphorylated in KATO-III but not in MKN7. In KATO-III, a number of tyrosine phosphorylated proteins, including extracellular signal-regulated protein kinases (ERKs) and epidermal growth factor receptor (EGFR), were observed irrespective of EGF stimulation and induction of ERK activity and EGFR tyrosine phosphorylation by EGF were less than that in MKN7.
  
  
  CONCLUSIONS
  Increased tyrosine kinase activities may cause diminished expression of E-cadherin and tyrosine phosphorylation of catenins, resulting in the abrogated cell-cell adhesion in gastric cancer cells.
authors.affiliation: Second Department of Internal Medicine, Showa University, School of Medicine, Tokyo, Japan.
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Ono
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Takeuchi
authors.forename: Jun-Ichi
authors.initials: J
authors.lastname: Ukegawa
authors.forename: Satoshi
authors.initials: S
authors.lastname: Kusayanagi
authors.forename: Keiji
authors.initials: K
authors.lastname: Mitamura
authors.forename: Michio
authors.initials: M
authors.lastname: Imawari
mesh_terms: D015820:Cadherins / Q000096:biosynthesis; D002448:Cell Adhesion / Q000502:physiology; D045744:Cell Line, Tumor; D003598:Cytoskeletal Proteins / Q000096:biosynthesis; D004815:Epidermal Growth Factor / Q000494:pharmacology; D006801:Humans; D010641:Phenotype; D010766:Phosphorylation; D011233:Precipitin Tests; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D013274:Stomach Neoplasms / Q000201:enzymology* / Q000473:pathology*
chemical_list: D015820:Cadherins; D003598:Cytoskeletal Proteins; D004815:Epidermal Growth Factor; D011505:Protein-Tyrosine Kinases